Patent · US Active

Epinephrine formulations

US12280024B2 · kind B2 · utility

0Cited by

7References

4Claims

0Family size

Assignee

Endo Operations Limited · IE

Inventors

Suketu Sanghvi · Kendall Park, US
Vinayagam Kannan · Rochester, US
Matthew Kenney · New Haven, US

Key dates

Filing date	Sep 28, 2023
Grant date	Apr 22, 2025
Priority date	—
Expiry date	Sep 28, 2043

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K9/0073
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Pharmaceutical compositions comprising epinephrine, methods of administration, and methods of making the same. Compositions may comprise at least one of an active agent, a pH raising agent, an antioxidant, a transition metal complexing agent, a pH lowering agent, a tonicity regulating agent, optionally a preservative, and optionally a solvent.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.